Who GLP-1 weight loss is for - and who it isn't Patients we typically work with on GLP-1 weight management: Adults with BMI 30+ (obesity) who have not achieved sustained weight loss with lifestyle change alone Adults with BMI 27+ and weight-related comorbidities - type 2 diabetes, hypertension, dyslipidemia, sleep apnea, prediabetes, fatty liver disease Patients with insulin resistance or metabolic syndrome where the metabolic and weight pictures are intertwined Patients post-bariatric surgery with weight regain, where appropriate and coordinated with their surgical team GLP-1 medications are not appropriate for patients with personal or family history of medullary thyroid carcinoma, MEN2 syndrome, history of pancreatitis, severe gastroparesis, or active eating disorders
It copies two gut hormones GIP and GLP-1 which together reduce appetite, slow how quickly your stomach empties, and help steady your blood sugar
Start your intake Typical Weight Loss at 2.5mg Tirzepatide Dosing The 2.5mg tirzepatide dose functions as a titration starting point designed to assess tolerability while initiating metabolic change
At 47, I stepped on the scale and saw 267 pounds staring back at me
Khan about any other medications you are currently taking, as Semaglutide GLP-1 may interact with them
Cost considerations and getting the most from your vial Understanding your conversion chart directly impacts cost efficiency